Back to Results
First PageMeta Content
Clinical research / Biosimilar / Biologic / Food and Drug Administration / Adverse effect / Pharmacy / Pharmaceutical drug / Pharmacology / Pharmaceutical sciences / Medicine


TESTIMONY OF ROBERT K. COUGHLIN PRESIDENT & CEO MASSACHUSETTS BIOTECHNOLOGY COUNCIL ON HOUSE BILL 3667 October 22, 2013
Add to Reading List

Document Date: 2013-11-01 14:06:43

Open Document

File Size: 112,78 KB

Share Result on Facebook

Company

MassBio / /

Continent

Europe / /

Holiday

Commonwealth Day / /

IndustryTerm

biologic product / manufacturing / molecules products / healthcare / separate manufacturing processes / /

Organization

FDA / Congress / COUNCIL ON HOUSE BILL / European Union / Committee on Health Care Financing / 620+ / /

Person

Walsh / Cusack / Robert Coughlin / /

Position

prescribing physician / fairly straight forward / authorized representative / Representative / leader / PRESIDENT & CEO MASSACHUSETTS BIOTECHNOLOGY / Chairman / pharmacist and the physician / President and CEO / Massachusetts General / /

ProvinceOrState

Massachusetts / /

Technology

BIOTECHNOLOGY / /

SocialTag